Borderline Personality Disorder Clinical Trial
— PAM-BOfficial title:
Effect on Relationship of a Brief Preventive Program: Pragmatic Pilot Randomized Controlled Trial." - Supportive Program for Mother With BPD
Borderline Personality Disorder (BPD) is characterized by a pervasive pattern of instability
of interpersonal relationships, self-image and emotions as well as marked impulsivity. When
patients have children, they are at high risk of severe emotional and relational
disturbances (withdrawal, low self-esteem, depression, suicidal thoughts). In addition,
studies support the effectiveness of parental guidance group to reduce emotional and
behavioral difficulties of children. To our knowledge there are no programs directed to
mothers with BPD who received a controlled evaluation.
From experience with parental guidance, data from the observation of children of patients
with BPD and psychosocial programs directed to patients BPD, we have built for preventive
intervention. The Supportive Program for Mothers with BPD (SuPMother-B) consists of 10 group
sessions providing information (education, childcare, care specific to BPD) and promotes
mother-child interactions (observation, games).
Purpose: Compare the effect of a program (SuPMother-B) group, of 10 sessions, offered to
mothers with a BPD in addition to a minimal intervention (diagnostic announcement and
provision of health care resources) on behavior withdrawal of children at 6 months compared
to a group of mothers receiving only minimal intervention.
Primary outcome: Difference at 6 months between the experimental and control groups on
scores on the assessment scale withdrawal (Alarm Distress Baby (ADBB)).
Status | Completed |
Enrollment | 10 |
Est. completion date | July 2014 |
Est. primary completion date | May 2014 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: Mother: - Women with children and at least one child aged 2 months to 2 years, Borderline Personality Disorder with SIDP (Structured Interview for DSM Personality Disorders) - age above 18 years - written consent Child: - ages between 2 months and 2 years, - parental consent for research participation. Exclusion Criteria: Mother: - chronic psychotic disorder, major depressive disorder, current mania or hypomania, - legal protection, - if no child can be included, the mother cannot be included. Child : •major psychomotor development disorder or psychiatric disorder according to the investigator. |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention
Country | Name | City | State |
---|---|---|---|
France | Service de psychiatrie de l'enfant et de l'adolescent - Hôpital La Grave - centre Hospitalier de Toulouse | Toulouse |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Toulouse |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Difference between the experimental and control groups on scores on the assessment scale withdrawal (Alarm Distress Baby (ADBB)). | Visit 3 at 6 months | No | |
Secondary | Brunet-Lezine Scale | This scale permits to assess the psychomotor development of the child. | Visit 2 (inclusion), 3 (6 months) and 4 (1 year) | No |
Secondary | Borderline Personality Disorder Severity Index (BPDSI) | Borderline Personality Disorder Severity Index (BPDSI) is a semi-structured interview assessing the frequency and severity of manifestations of borderline personality disorders of the mother during an agreed period (3 months to 1 year). | Visit 2 (inclusion), 3 (6 months) and 4 (1 year) | No |
Secondary | Global Assessment Scale | This scale corresponds to the 5th axis of the Diagnostic and Statistical Manual of Mental Disorders (DSM) and permits to assess the overall functioning of the mother. | Visit 2 (inclusion), Visit 3 (6 months), Visit 4 (1 Year) | No |
Secondary | Difference between the experimental and control groups on scores on the assessment scale withdrawal (Alarm Distress Baby (ADBB)). | Visit 2 (inclusion) and visit 4 (1 Year) | No | |
Secondary | M.I.N.I. 5.0.0 French version | Structured interview to assess 17 disorders such as actual or passed depression, mania, abuse... | Visit 2 (inclusion), Visit 3 (6 months), Visit 4 (1 year) | No |
Secondary | Parenting Sense of Competence Scale (P.S.O.C) | This scale assess the perceived competence of the parent's role as educator. | Visit 2 (inclusion), Visit 3 (6 months), Visit 4 (1 year) | No |
Secondary | social and demographic data | marital status, profession, socio-economic level, number of children | Visit 2 (inclusion), Visit 3 (6 months), Visit 4 (1 year) | No |
Secondary | Data on care pathways | Questionnaire established by the research team to evaluate the use of care services by the mothers and children. | Visit 2 (inclusion), Visit 3 (6 months), Visit 4 (1 year) | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04856449 -
DBT Skills Plus EMDR for BPD and Trauma
|
N/A | |
Active, not recruiting |
NCT04587518 -
Five Factor Model Treatment for Borderline Personality Disorder
|
N/A | |
Recruiting |
NCT05651295 -
A Precision Medicine Approach to Target Engagement for Emotion Regulation
|
N/A | |
Completed |
NCT03677037 -
The Short-Term MBT Project
|
Phase 3 | |
Not yet recruiting |
NCT05989529 -
Delving Into Borderline Personality Disorder Clinical Trial Experiences
|
||
Completed |
NCT02518906 -
Evaluation of AIT Study
|
N/A | |
Completed |
NCT02068326 -
MBT in Groups for Adolescents With BPD or Subthreshold BPD Versus TAU - the M-GAB Randomized Controlled Trial
|
N/A | |
Recruiting |
NCT04296604 -
Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations
|
N/A | |
Terminated |
NCT02149823 -
Examining Dose-Related Effects of Oxytocin on Social Cognition Across Populations
|
Phase 1 | |
Completed |
NCT02108990 -
Acetaminophen and Social Processes
|
Phase 2 | |
Not yet recruiting |
NCT01683136 -
Evaluation of the HBDL Coil Transcranial Magnetic Stimulation (TMS) Device - Feasibility Study for the Treatment of Borderline Personality Disorder
|
N/A | |
Completed |
NCT01635556 -
Evaluation of a Modified Dialectical Behavior Therapy Program
|
N/A | |
Completed |
NCT02988037 -
Adapted Dialectical Behaviour Therapy for Adolescents With Deliberate Self-Harm: A Pre-post Observational Study
|
N/A | |
Completed |
NCT02397031 -
Mindfulness and Interpersonal Effectiveness Skills in Borderline Personality Disorder
|
N/A | |
Terminated |
NCT01212588 -
Preliminary Trial of the Effect of Glucocorticoid Receptor Antagonist on Borderline Personality Disorder (BPD)
|
Phase 2 | |
Terminated |
NCT01103180 -
Selective Serotonin Reuptake Inhibitors (SSRIs) in Borderline Personality Disorder
|
Phase 2 | |
Terminated |
NCT00539188 -
N-Acetylcysteine in Adjunct to DBT for the Treatment of Self-Injurious Behavior in BPD
|
Phase 2 | |
Recruiting |
NCT05398627 -
Neurofeedback for Borderline Personality Disorder
|
N/A | |
Recruiting |
NCT03994510 -
SHame prOpensity in bOrderline Personality Disorder
|
N/A | |
Recruiting |
NCT06005129 -
Personality Change Study for Borderline Personality Disorder
|
N/A |